scholarly journals Impact of Depression on Quality of Life Results in Patients Following Acute Coronary Syndrome Treated with Percutaneous Coronary Intervention (PCI)

2013 ◽  
Vol 03 (06) ◽  
Author(s):  
Jankowska Polanska Beata
2021 ◽  
Vol 2 (2) ◽  
pp. 15-20
Author(s):  
Wella Karolina ◽  
Mohammad Saifur Rohman ◽  
Pawik Supriadi ◽  
Djanggan Sargowo ◽  
Wira Kimahesa Anggoro ◽  
...  

Background : The benefit of PCI to improve quality of life (QoL) in chronic coronary syndrome (CCS) is still unclear. Objectives : This study aimed to assess the benefit of percutaneous coronary intervention (PCI) in improving QoL among CCS patients receiving OMT. Methods : We conducted a retrospective cohort study. CCS patients who underwent coronary angiography (CAG) and/or PCI were grouped into OMT plus PCI and OMT groups. The SYNTAX score was used to assess the complexity and severity of coronary artery lesions. The outcome measured was QoL assessed using Seattle Angina Questionnaire (SAQ) and rehospitalization. Results: A total of 57 patients in the OMT plus PCI group and 49 patients in the OMT group were included. The percentage of patients with good QoL was higher in the OMT plus PCI group than OMT only group (64.5% vs. 35.5%; p = 0.007). The OMT plus PCI group revealed a better activities of daily living (85.11 ± 12.46 vs. 12.46 ± 21.87; p = 0.014) and angina stability (84.32 ± 23.63 vs. 71.81 ± 27.89; p = 0.014) than OMT group. Among patients with SYNTAX scores of more than 22, achievement of good QoL was greater in the OMT plus PCI group than the OMT group (80.8% vs. 45.5%; p = 0.025). Conclusion: PCI improved the QoL in CCS patients treated with OMT. Second, OMT plus PCI improves physical limitation and angina stability. For patients with a SYNTAX score of more than 22, OMT plus PCI was correlated with good QoL achievement.


2021 ◽  
Vol 25 (4) ◽  
pp. 64
Author(s):  
A. S. Klinkova ◽  
O. V. Kamenskaya ◽  
I. Yu. Loginova ◽  
A. M. Chernyavskiy ◽  
V. V. Lomivorotov

<p><strong>Aim.</strong> To study the quality of life and how it is influenced by different factors in the long term after myocardial re-vascularisation in patients with coronary artery disease who had acute coronary syndrome during the coronavirus disease 2019 (COVID-19) pandemic.</p><p><strong>Methods.</strong> We examined 658 patients with coronary artery disease and acute coronary syndrome (mean age 66.4 ± 4.3 years). Percutaneous coronary intervention (600 patients) and coronary artery bypass grafting with cardio-pulmonary bypass (58 patients) were performed. Six months after myocardial re-vascularisation, we assessed patients' quality of life using the SF-36 questionnaire. We identified factors that affect the quality of life using multivariate regression analysis.</p><p><strong>Results.</strong> After myocardial revascularisation, the patients had a reduced overall indicator of physical health (&lt; 40 points). The overall indicator of psycho-emotional health was higher than physical (p &lt; 0.002) but did not exceed 50 points. We noted the adverse effect of COVID-19 (regardless of disease severity) on the assessment. Also, COVID-19 was associated with increased anxiety. A history of concomitant diabetes mellitus, obesity, stroke and percutaneous coronary intervention had a negative effect on the overall indicators of physical and mental health.</p><p><strong>Conclusion. </strong>Patients with coronary artery disease who had acute coronary syndrome after myocardial re-vascularisation are characterised by reduced indicators of physical and average indicators of mental health in the long term. COVID-19, regardless of disease severity, has a negative impact on patients' general state of health, social activity and emotional background. A history of diabetes mellitus, obesity, stroke and percutaneous coronary intervention adversely affects the physical and mental health indicators.</p><p>Received 4 August 2021. Revised 31 August 2021. Accepted 1 September 2021.</p><p><strong>Funding:</strong> This work was carried out within the framework of the state task of the Ministry of Health of the Russian Federation (No. 121031300225-8).</p><p><strong>Conflict of interest:</strong> Authors declare no conflict of interest.</p><p><strong>Contribution of the authors<br /> </strong>Conception and study design: O.V. Kamenskaya, V.V. Lomivorotov<br /> Data collection and analysis: A.S. Klinkova<br /> Statistical analysis: A.S. Klinkova<br /> Drafting the article: A.S. Klinkova, I.Yu. Loginova<br /> Critical revision of the article: O.V. Kamenskaya, A.M. Chernyavskiy<br /> Final approval of the version to be published: A.S. Klinkova, O.V. Kamenskaya, I.Yu. Loginova, A.M. Chernyavskiy, V.V. Lomivorotov</p>


Sign in / Sign up

Export Citation Format

Share Document